ha praticamente chiuso quello superiore in apertura a max 3,13€ , ed anche quello inferiore poco fa con minimi a 2,77€. Che figli di ****ana
ADMA Biologics, Inc. (ADMA)
- Creatore Discussione legolego
- Data di inizio
-
Obbligazione Societe Generale – Tasso fisso in Euro
Questa obbligazione prevede il pagamento di tre cedole fisse, corrisposte su base semestrale, ad un tasso annuo lordo del 3,25% e il rimborso del 100% del Valore Nominale a scadenza. Durante la sua vita, il valore di mercato dell’obbligazione può essere diverso dal Valore Nominale. L’investitore potrà quindi acquistare l’obbligazione a prezzi inferiori o superiori al Valore Nominale; il rimborso del Valore Nominale è garantito esclusivamente a scadenza.
Per continuare a leggere visita il link
ha praticamente chiuso quello superiore in apertura a max 3,13€ , ed anche quello inferiore poco fa con minimi a 2,77€. Che figli di ****ana
chavallo67
Nuovo Utente
- Registrato
- 16/3/05
- Messaggi
- 12.572
- Punti reazioni
- 284
il mio obiettivo era "la ricerca del GAP"... poi se uno dorme !! (il sottoscritto :fagiano
mi pare sia chiuso .. resta che MACD di incrocia (al rialzo) vediamo..
ps certo che se un giorno Wall Street sale e l'altro scende non diventa facile ...
pierlala
Nuovo Utente
- Registrato
- 15/6/17
- Messaggi
- 1.350
- Punti reazioni
- 40
Nonostante ci avessi fatto un pensiero...come uno s********...non ho venduto in apertura
Tu come ti comporterai...avendo fatto entrambi i gap sup e inf il trend è rialzista...
Scusami la domanda ma come dico sempre non mastico A.T.
Grazie
pierlala
Nuovo Utente
- Registrato
- 15/6/17
- Messaggi
- 1.350
- Punti reazioni
- 40
il mio obiettivo era "la ricerca del GAP"... poi se uno dorme !! (il sottoscritto :fagiano
mi pare sia chiuso .. resta che MACD di incrocia (al rialzo) vediamo..
ps certo che se un giorno Wall Street sale e l'altro scende non diventa facile ...
Stai tranquillo che riguardo a sonno...sei in buona compagnia
chavallo67
Nuovo Utente
- Registrato
- 16/3/05
- Messaggi
- 12.572
- Punti reazioni
- 284
a essere "svegli" c'era da fare del Grano facile oggi...
segnamocela x la prossima volta
pierlala
Nuovo Utente
- Registrato
- 15/6/17
- Messaggi
- 1.350
- Punti reazioni
- 40
a essere "svegli" c'era da fare del Grano facile oggi...
segnamocela x la prossima volta
Infatti è anche quello che mi fa rodere di più...si vendeva a 3...si riacquistava a 2.77 e si rivendeva...
Adesso Big si irriterà dicendomi che col senno del poi...ma lui sicuramente avrà fatto così...
Ovviamente il quadro adesso è mano facile da leggere...
Non ci sono altri segnali evidenti di un movimento Up e nemmeno Down. In queste fasi si monitora e ci si fanno in testa gli "Scenari":
- Best scenario...
- Worst scenario...
inoltre dipende dal tempo dell'investimento : brevissimo, breve, medio, lungo. Io per ora rimango dentro...ma osservo gli indici e sto attento se "sbraca" tutto. La volatilità del mercato è "un po'" in aumento (vedi il VIX), non è un buon segno di stabilità del trend
pierlala
Nuovo Utente
- Registrato
- 15/6/17
- Messaggi
- 1.350
- Punti reazioni
- 40
Dr Strangelove
Nuovo Utente
- Registrato
- 17/8/17
- Messaggi
- 186
- Punti reazioni
- 20
io sono l ultimo arrivato ma ho imparato che il mondo non finisce oggi pomeriggio, ne ho ripreso un po a 2,82 e altro ordine a 2,76 ..
col grano/wheat sono sotto
col grano/wheat sono sotto
chavallo67
Nuovo Utente
- Registrato
- 16/3/05
- Messaggi
- 12.572
- Punti reazioni
- 284
chavallo67
Nuovo Utente
- Registrato
- 16/3/05
- Messaggi
- 12.572
- Punti reazioni
- 284
chiusura
..
..
A quanto pare di recente alcuni medici hanno riscontrato una particolare sindrome associata al COVID-19, associata in particolare ai bambini:
19.05.2020 : Multisystem Inflammatory Syndrome in Children Associated with COVID-19
https://emergency.cdc.gov/coca/ppt/2020/COCA_Call_Slides_05_19_2020.pdf
21.05.2020 Anche negli USA:
Colorado sees cases of possible coronavirus-linked mystery illness in kids: report
Colorado sees cases of possible coronavirus-linked mystery illness in kids: report | Fox News
"...the syndrome has been said to affect children who test positive for a current or recent infection of SARS-CoV-2, the novel coronavirus that causes COVID-19..."
21.05.2020 : ed in particolare nello stato di New York
Doctors say CDC-backed treatment for kids with inflammatory syndrome linked to coronavirus is ‘highly effective’
Doctors say CDC-backed treatment for kids with inflammatory syndrome linked to coronavirus is ‘highly effective’
"....The organization noted that a direct link between coronavirus and MIS-C has not been drawn but that “many children with MIS-C had the virus that causes COVID-19, or had been around someone with COVID-19.” The syndrome has proven deadly in at least a handful of cases, but in the most promising news thus far, the CDC revealed this week that doctors have found a treatment — one that’s not only lessening symptoms, but allowing kids to leave the hospital feeling back to normal...."
In particolare in quest'ultimo articolo due pediatri illustrano il trattamento di questi sintomi mediante IGIV (le immunoglobuline), con risultati estremamente incoraggianti. Non la definiscono una "cura", ma un trattamento per il momento:
..."......." Head of the pediatric infectious diseases division at Children’s Hospital of Philadelphia Dr. Audrey John has seen some cases of MIS-C in her department and has seen major success treating kids with it. She describes IVIG as “pooled antibodies” which can be “used to provide immunity to people who don’t make their own antibodies.” She notes that it is the standard treatment for Kawasaki disease (KD), a rare inflammatory syndrome in kids that has many overlapping symptoms with MIS-C.
Dr. Stanford Shulman, a professor of pediatrics with a focus on infectious disease at Northwestern University, adds that IVIG — which is made through blood plasma donations — often comes from students. “IVIG is prepared through plasma donations from the large groups of adults donating plasma, usually on college campuses or nearby,” Shulman says."...
19.05.2020 : Multisystem Inflammatory Syndrome in Children Associated with COVID-19
https://emergency.cdc.gov/coca/ppt/2020/COCA_Call_Slides_05_19_2020.pdf
21.05.2020 Anche negli USA:
Colorado sees cases of possible coronavirus-linked mystery illness in kids: report
Colorado sees cases of possible coronavirus-linked mystery illness in kids: report | Fox News
"...the syndrome has been said to affect children who test positive for a current or recent infection of SARS-CoV-2, the novel coronavirus that causes COVID-19..."
21.05.2020 : ed in particolare nello stato di New York
Doctors say CDC-backed treatment for kids with inflammatory syndrome linked to coronavirus is ‘highly effective’
Doctors say CDC-backed treatment for kids with inflammatory syndrome linked to coronavirus is ‘highly effective’
"....The organization noted that a direct link between coronavirus and MIS-C has not been drawn but that “many children with MIS-C had the virus that causes COVID-19, or had been around someone with COVID-19.” The syndrome has proven deadly in at least a handful of cases, but in the most promising news thus far, the CDC revealed this week that doctors have found a treatment — one that’s not only lessening symptoms, but allowing kids to leave the hospital feeling back to normal...."
In particolare in quest'ultimo articolo due pediatri illustrano il trattamento di questi sintomi mediante IGIV (le immunoglobuline), con risultati estremamente incoraggianti. Non la definiscono una "cura", ma un trattamento per il momento:
..."......." Head of the pediatric infectious diseases division at Children’s Hospital of Philadelphia Dr. Audrey John has seen some cases of MIS-C in her department and has seen major success treating kids with it. She describes IVIG as “pooled antibodies” which can be “used to provide immunity to people who don’t make their own antibodies.” She notes that it is the standard treatment for Kawasaki disease (KD), a rare inflammatory syndrome in kids that has many overlapping symptoms with MIS-C.
Dr. Stanford Shulman, a professor of pediatrics with a focus on infectious disease at Northwestern University, adds that IVIG — which is made through blood plasma donations — often comes from students. “IVIG is prepared through plasma donations from the large groups of adults donating plasma, usually on college campuses or nearby,” Shulman says."...
chavallo67
Nuovo Utente
- Registrato
- 16/3/05
- Messaggi
- 12.572
- Punti reazioni
- 284
mi sono imbattuto su questo analista
Raghuram (ram) Selvaraju | Relief Therapeutics | Switzerland
che venerdì ha dato reiterated Buy TP $12
sul sito https://www.tipranks.com/stocks/adma/price-target
non conosco l'affidabilità ne di uno ne dell'altro ... ma meglio avere BUY che Sell..
.
Raghuram (ram) Selvaraju | Relief Therapeutics | Switzerland
che venerdì ha dato reiterated Buy TP $12
sul sito https://www.tipranks.com/stocks/adma/price-target
non conosco l'affidabilità ne di uno ne dell'altro ... ma meglio avere BUY che Sell..
.
chavallo67
Nuovo Utente
- Registrato
- 16/3/05
- Messaggi
- 12.572
- Punti reazioni
- 284
JUN 2, 2020 2:00 PM EDT
Jefferies Virtual Healthcare Conference
Events & Webcasts :: ADMA Biologics, Inc. (ADMA)
apertura intorno a 3.03/04
..
Jefferies Virtual Healthcare Conference
Events & Webcasts :: ADMA Biologics, Inc. (ADMA)
apertura intorno a 3.03/04
..
Dr Strangelove
Nuovo Utente
- Registrato
- 17/8/17
- Messaggi
- 186
- Punti reazioni
- 20
ripresa ieri in due tranche, pmc 2,88
Dr Strangelove
Nuovo Utente
- Registrato
- 17/8/17
- Messaggi
- 186
- Punti reazioni
- 20
già visto verde e venduta 3,28
visto verde e venduta 3,28
Dr Strangelove
Nuovo Utente
- Registrato
- 17/8/17
- Messaggi
- 186
- Punti reazioni
- 20
rientrato a 3,05 ..non si sa mai
BigNick
Siamo solo noi
- Registrato
- 10/7/01
- Messaggi
- 9.091
- Punti reazioni
- 437
ADMA Biologics Opens Its Newest ADMA BioCenters Plasma Collection Facility
Published: Jul 06, 2020
RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., July 06, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the commencement of operations and initiation of collections at its newest ADMA BioCenters plasma collection facility located in Knoxville, TN. ADMA also announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for this second plasma collection center.
“We are extremely pleased to announce the opening and commencement of operations at our second and newest ADMA BioCenters plasma collection facility,” said Adam Grossman, President and Chief Executive Officer of ADMA. “The opening of the Knoxville center is an important step in our expansion plans and puts us on track to achieve our goal of opening five to 10 new plasma collection centers by the end of 2022.”
This new, state-of-the-art plasma collection center features automated registration, high-tech collection equipment designed to shorten the donation process, free Wi-Fi wireless network in the donor collection area, individual flat screen TVs with cable at each donor station, and highly trained and certified staff who put donor comfort and safety first.
The FDA regulatory process for obtaining approval for this plasma collection center includes a site inspection and an approximately 12-month BLA review period. As such, ADMA expects to receive an approval decision for this second plasma facility in mid-2021. In the meantime, ADMA is permitted to collect plasma donations at this site, and once FDA approved, it can use the plasma collected for production of its FDA approved immunoglobulin products.
Published: Jul 06, 2020
RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., July 06, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the commencement of operations and initiation of collections at its newest ADMA BioCenters plasma collection facility located in Knoxville, TN. ADMA also announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) seeking approval for this second plasma collection center.
“We are extremely pleased to announce the opening and commencement of operations at our second and newest ADMA BioCenters plasma collection facility,” said Adam Grossman, President and Chief Executive Officer of ADMA. “The opening of the Knoxville center is an important step in our expansion plans and puts us on track to achieve our goal of opening five to 10 new plasma collection centers by the end of 2022.”
This new, state-of-the-art plasma collection center features automated registration, high-tech collection equipment designed to shorten the donation process, free Wi-Fi wireless network in the donor collection area, individual flat screen TVs with cable at each donor station, and highly trained and certified staff who put donor comfort and safety first.
The FDA regulatory process for obtaining approval for this plasma collection center includes a site inspection and an approximately 12-month BLA review period. As such, ADMA expects to receive an approval decision for this second plasma facility in mid-2021. In the meantime, ADMA is permitted to collect plasma donations at this site, and once FDA approved, it can use the plasma collected for production of its FDA approved immunoglobulin products.